Covista
CVSA NYSE· Education Services
Last close · Oct 26, 2026
$131.55
KIRA · Stoqly’s AI analyst, in plain words
- Covista had $2.0B of revenue in fiscal 2026, up 9.3% on the year before. Over five years, revenue changed +16.8% a year on average.
- Its operating margin was 19.6%, up 0.5 pts: of every 100 in sales, about 20 is left after running the business.
- Covista made $252M of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 15.6% a year.
- Free cash flow was $393M in fiscal 2026, 20.1% of revenue.
- Covista returned $240M to shareholders in fiscal 2026, 61% of free cash flow. The diluted share count fell 6.8%.
- Covista owes $257M more than it holds in cash, about 0.6 years of operating profit.
Market cap
$4.7B
P/E
—
Revenue
$2.0B
Net income
$252M
Free cash flow
$393M
Operating margin
19.6%
Covista in 30 seconds · fiscal 2026
Are sales growing?
+9.3%
Yes. Sales grew 9.3% last year.
Does it make a profit?
12.9%
Yes. It keeps 12.9% of every sale as profit.
Does profit turn into cash?
20.1%
Yes. 20.1% of sales ends up as free cash.
Is debt under control?
0.6x
Yes. It could repay its debt with 0.6 years of operating profit.
How healthy are the accounts?
8 / 9
Solid. It passes 8 of 9 health tests.
What Covista does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Aug 6, 2026
- Legal name
- Covista Inc.
- CIK
- 0000730464
Covista · CVSA
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.4B | $1.5B | $1.6B | $1.8B | $2.0B |
| Revenue growth | 53.7% | 5.0% | 9.2% | 12.9% | 9.3% |
| Gross margin | 52.3% | 55.3% | 55.9% | 56.9% | 57.3% |
| Operating margin | 5.6% | 11.6% | 13.7% | 19.1% | 19.6% |
| Net income | $311M | $93.4M | $137M | $237M | $252M |
| Net margin | 22.5% | 6.4% | 8.6% | 13.3% | 12.9% |
| Diluted EPS | $6.43 | $2.05 | $3.39 | $6.18 | $7.04 |
| Cash | |||||
| Cash from operations | $10.6M | $192M | $296M | $338M | $470M |
| Capital expenditure | $31.1M | $26.0M | $48.9M | $50.3M | $77.7M |
| Free cash flow | −$20.5M | $166M | $247M | $288M | $393M |
| FCF margin | −1.5% | 11.4% | 15.6% | 16.1% | 20.1% |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $120M | $123M | $262M | $213M | $240M |
| Share count change | −6.3% | −5.8% | −11.6% | −4.9% | −6.8% |
| Debt and strength | |||||
| Cash and short-term investments | $347M | $272M | $219M | $200M | $406M |
| Debt incl. finance leases | $839M | $695M | $649M | $553M | $663M |
| Shareholders' equity | $1.5B | $1.5B | $1.4B | $1.4B | $1.4B |
| Net debt / EBITDA | 2.3x | 1.6x | 1.5x | 0.9x | 0.6x |
| Current ratio | 1.3x | 1.1x | 0.9x | 0.8x | 1.1x |
| Interest coverage | 0.6x | 2.7x | 3.4x | 6.5x | 8.4x |
| Returns and quality | |||||
| Return on capital | 3.1% | 7.9% | 9.9% | 14.9% | 17.0% |
| Return on equity | 22.3% | 6.3% | 9.7% | 16.9% | 17.5% |
| Piotroski F-score | 7 | 7 | 8 | 8 | 8 |
| Altman Z'' | 4.0 | 4.4 | 4.4 | 5.1 | 5.2 |
Insiders bought, 12 months
$3.9M
2 insiders
Insiders sold, 12 months
$10.3M
5 insiders
Of sales under plans
100%
$10.3M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Covista · CVSA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Covista CVSA | $4.7B | 9.3% | 19.6% | 20.1% | 17.0% | — | 8 |
| Laureate Education LAUR | $5.5B | 8.6% | 25.3% | 15.5% | 28.6% | 17.7x | 8 |
| Stride LRN | $3.5B | 4.7% | 17.9% | 17.2% | 31.3% | 10.8x | 6 |
| Strategic Education STRA | $1.8B | 4.0% | 13.7% | 12.1% | 8.4% | 13.6x | 6 |
| Grand Canyon Education LOPE | $4.3B | 7.1% | 24.0% | 21.6% | 45.3% | 19.8x | 4 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $131.55 a share, the company is worth $4.7B.
Covista grew sales faster than 4 of its 4 similar companies.
Source: SEC EDGAR XBRL filings (CIK 0000730464). Data updated October 19, 2026. For information only — not investment advice. Check the original filings before relying on any figure.